Science · 1 views
Experimental One-Dose Treatment Cuts 'Bad' Cholesterol by 52% in First Human Trial
This could be a breakthrough. ScienceAlert stories are written, fact-checked, and edited by humans, never generated by AI.
Source Story Brief Updated 56m ago
Science 
Story intelligence Beta
Confidence Limited Single-outlet story
Views 1 Community interest
Brief read ~34 words
Story Brief
Too much 'bad' cholesterol in the bloodstream – that's the low-density lipoprotein (LDL) type – can contribute to plaque buildup in the arteries, increasing the risk of cardiovascular problems like heart attacks and strokes.
Read full article on SciencealertAI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Science
Continue reading recent Science coverage
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow